IRADIMED CORPORATION (IRMD) Total liabilities 2016–2025
IRADIMED CORPORATION (IRMD) total liabilities at each fiscal year-end, per SEC filings.
$14.2MFY2025 · since FY2016: $5.3M → $14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.2M | +23.0% |
| FY2024 | $11.5M | -44.5% |
| FY2023 | $20.7M | +75.1% |
| FY2022 | $11.8M | +10.6% |
| FY2021 | $10.7M | +10.6% |
| FY2020 | $9.7M | -13.6% |
| FY2019 | $11.2M | +72.5% |
| FY2018 | $6.5M | +6.8% |
| FY2017 | $6.1M | +14.6% |
| FY2016 | $5.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Gross marginIRMD Operating incomeIRMD Operating marginIRMD Operating cash flowIRMD Free cash flowIRMD Capital expendituresIRMD Return on equityIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Shareholders’ equityIRMD overview →